Products

Detection Kit

SARS-CoV-2 Multiplex assay

SARS-CoV-2_Multiplex_assay

Simultaneous detection of 3 COVID-19 target region without RNA extraction.

 

  • Direct, fast, reliable, and multiple gene detection for SARS-CoV-2
  • DIRECT: Applicable to both purified RNA and unpurified specimens
  • FAST: 50 mins [5 mins for sample preparation + 45 mins/40 cycles for qRT-PCR]
  • RELIABLE: 4 target detection for SARS-CoV-2 (S, ORF8, N) and human (RNase P)
  • UDG System: Prevention of carryover contamination

Products

Cat.No. Product Size
DFSCV100 DirectFast™ SARS-CoV-2 Multiplex assay, RUO 100 tests
DirectFast™ SARS-CoV-2 Multiplex assay, a probe-based real-time RT-PCR kit, is designed for ‘DIRECT’ and ‘FAST’ detection of SARS-CoV-2 RNA. Crude RNA samples prepared by a lysis buffer (NAExDB) or heating, as well as purified RNA, could be used as templates for this assay kit without compromising detection sensitivity and accuracy. And this kit allows the fast reaction to complete the real-time RT-PCR cycles within one hour (45-50 min for 40 cycles). The target multiplicity (ORF8, N, S genes of SARS-CoV-2) lowers the risk of false-negative results induced by mutations of the viral RNA. Additionally, this assay installs a heat-labile UDG (Uracil-DNA glycosylase) and dUTP system to prevent carryover contamination.

 

 

Workflow of DirectFast™ SARS-CoV-2 Multiplex assay

Copyright ⓒ NanoHelix Co., Ltd. All rights reserved.